TEZEFORT
80MG/5MG TBL NOB 28
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Resumption of marketing | 05.09.2022 | |||
| Interruption of marketing | 13.07.2022 |
0133989, 0167852 |
Manufacturing reasons | 16.09.2022 |
| Resumption of marketing | 19.05.2022 | |||
| Interruption of marketing | 27.01.2022 |
0133989, 0167852, 0206208 |
Manufacturing reasons | 27.05.2022 |
| Resumption of marketing | 07.04.2020 | |||
| Interruption of marketing | 11.03.2020 |
0133989, 0167852 |
Manufacturing reasons | 08.04.2020 |
| Resumption of marketing | 06.11.2018 | |||
| Interruption of marketing | 16.10.2018 |
0133989, 0167852, 0206208 |
Manufacturing reasons | NA |
| Resumption of marketing | 25.01.2018 | |||
| Interruption of marketing | 23.01.2018 |
0167852 |
||
| Resumption of marketing | 13.09.2017 | |||
| Interruption of marketing | 28.08.2017 |
0167852 |
||
| Resumption of marketing | 24.04.2017 | |||
| Interruption of marketing | 19.04.2017 |
0167852 |
||
| Placing on the market | 27.09.2016 |
All reports are available in the Overview.
cz